The C-514T polymorphism of hepatic lipase gene modulates the impact of a high carbohydrate diet on lipid profile in healthy Chinese young adults

Open access


Background: Serum lipid concentrations are associated with genetic and environmental factors. Studies of interaction between genetic variations and diets may provide more insight into the mechanisms of lipid metabolism and the development of coronary heart disease.

Objective: We studied the interaction of a common C-to-T substitution at position -514 of the hepatic lipase promoter with high carbohydrate diet in a young and healthy Chinese population lipid profiles.

Methods: Fifty-six young, healthy Chinese subjects were given stabilization diets of 54% carbohydrate to exclude interference from the dietary background of the subjects. This was followed with a high carbohydrate diet of 70%. We analyzed the serum lipid profiles at baseline, after the stabilization diet, and after the high carbohydrate diet. Hepatic lipase gene polymorphisms were also determined.

Results: After the high carbohydrate diet, almost the whole population had significantly lower levels of phospholipids and all the females showed significantly higher levels of triacylglycerol (TAG). Notably, carriers of C allele had significantly lower levels of low-density lipoprotein cholesterol (LDL-C). Males with CC, CT genotypes and females with CC genotype had significantly lower levels of total cholesterol. Furthermore, CC genotype males showed significantly increased high-density lipoprotein cholesterol (HDL-C). A significant difference in the hepatic lipase C-514T polymorphism was found in phospholipid of males with TT >CT >CC.

Conclusion: Our results demonstrated that the C-514T polymorphism in the hepatic lipase gene could modulate the impact of a high carbohydrate diet on lipid profiles in this young and healthy Chinese cohort. This influence is gender-specific.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Margolis S Dobs AS. Nutritional management of plasma lipid disorders. J Am Coll Nutr. 1989; 8 Suppl: 33S-45S.

  • 2. Perez-Jimenez F Lopez-Miranda J Mata P. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis. 2002; 163:385-98.

  • 3. Dreon DM Fernstrom HA Miller B Krauss RM. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. Faseb J. 1994; 8:121-6.

  • 4. Kasim-Karakas SE Almario RU Mueller WM Peerson J. Changes in plasma lipoproteins during low-fat high-carbohydrate diets: effects of energy intake. The American journal of clinical nutrition. 2000; 71:1439-47.

  • 5. Harland JO Unwin N Bhopal RS White M Watson B Laker M et al. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health. 1997; 51: 636-42.

  • 6. Heng CK Saha N Low PS. Evolution of the apolipoprotein B gene and coronary artery disease: a study in low and high risk Asians. Ann Hum Genet. 1999; 63:45-62.

  • 7. Chen Z Shu XO Yang G Li H Li Q Gao YT et al. Nutrient intake among Chinese women living in Shanghai China. Br J Nutr. 2006; 96:393-9.

  • 8. Saleheen D Frossard P. CAD risk factors and acute myocardial infarction in Pakistan. Acta Cardiol. 2004; 59:417-24.

  • 9. Parks EJ Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. The American journal of clinical nutrition. 2000; 71:412-33.

  • 10. Fried SK Rao SP. Sugars hypertriglyceridemia and cardiovascular disease. The American journal of clinical nutrition. 2003; 78:873S-80S.

  • 11. Codario RA. Hypertriglyceridemia and cardiovascular disease management. J Am Acad Nurse Pract. 2007; 19(12 Suppl 2):7-10 3-4.

  • 12. Fonseca N Bernardino L Silvestre I Santos J Seixo F Mendes L et al. Acute myocardial infarction in patients aged under 45 years. Rev Port Cardiol. 2004; 23:1585-91.

  • 13. Glimcher LH Lee AH. From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. Ann N Y Acad Sci. 2009; 1173 Suppl 1: E2-9.

  • 14. Salati LM Szeszel-Fedorowicz W Tao H Gibson MA Amir-Ahmady B Stabile LP et al. Nutritional regulation of mRNA processing. The Journal of nutrition. 2004; 134:2437S-43S.

  • 15. Connelly PW Hegele RA. Hepatic lipase deficiency. Crit Rev Cl Lab Sci. 1998; 35:547-72.

  • 16. Hill SA McQueen J. Reverse cholesterol transport - A review of the process and its clinical implications. Clin Biochem. 1997; 30:517-25.

  • 17. Zambon A Deeb SS Pauletto P Crepaldi G Brunzell JD. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol. 2003; 14:179-89.

  • 18. Zambon A Deeb SS Hokanson JE Brown BG Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity buoyant LDL and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998; 18:1723-9.

  • 19. Couture P Otvos JD Cupples LA Lahoz C Wilson PW Schaefer EJ et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2000; 20:815-22.

  • 20. Tahvanainen E Syvanne M Frick MH Murtomaki- Repo S Antikainen M Kesaniemi YA et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. The Journal of clinical investigation. 1998; 101:956-60.

  • 21. Wood KC Fullerton MD El-Sohemy A Bakovic M. Interactions between hepatic lipase and apolipoprotein E gene polymorphisms affect serum lipid profiles of healthy Canadian adults. Appl Physiol Nutr Metab. 2008; 33:761-8.

  • 22. Jansen H Verhoeven AJ Weeks L Kastelein JJ Halley DJ van den Ouweland A et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol. 1997; 17:2837-42.

  • 23. Leclerc I Davignon I Lopez D Garrel DR. No change in glucose tolerance and substrate oxidation after a high-carbohydrate low-fat diet. Metabolism. 1993; 42: 365-70.

  • 24. Schwarz JM Linfoot P Dare D Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat low-carbohydrate and low-fat high-carbohydrate isoenergetic diets. American Journal of Clinical Nutrition. 2003; 77:43-50.

  • 25. Guerra R Wang J Grundy SM Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. P Natl Acad Sci USA. 1997; 94:4532-7.

  • 26. Satoh H Nishino T Tomita K Tsutsui H. Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men. Circ J. 2006; 70:227-31.

  • 27. Lee MM Wu-Williams A Whittemore AS Zheng S Gallagher R Teh CZ et al. Comparison of dietary habits physical activity and body size among Chinese in North America and China. Int J Epidemiol. 1994; 23:984-90.

  • 28. Masson LF McNeill G Avenell A. Genetic variation and the lipid response to dietary intervention: a systematic review. The American journal of clinical nutrition. 2003; 77:1098-111.

  • 29. Masson LF McNeill G. The effect of genetic variation on the lipid response to dietary change: recent findings. Curr Opin Lipidol. 2005; 16:61-7.

  • 30. Price TM O’Brien SN Welter BH George R Anandjiwala J Kilgore M. Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution. Am J Obstet Gynecol. 1998; 178:101-7.

  • 31. Murtomaki S Tahvanainen E Antikainen M Tiret L Nicaud V Jansen H et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol. 1997; 17:1879-84.

  • 32. Brand K Dugi KA Brunzell JD Nevin DN Santamarina-Fojo S. A novel A?G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996; 37: 1213-23.

Journal information
Impact Factor
5-year IMPACT FACTOR: 0.293

CiteScore 2018: 0.30

SCImago Journal Rank (SJR) 2018: 0.172
Source Normalized Impact per Paper (SNIP) 2018: 0.237

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 145 88 3
PDF Downloads 44 27 0